欢迎来到 APExBIO中国区代理商/公司/官网
全国咨询热线: 13212737804
联系我们

地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301

电话:18771149750

传真:18372041646

邮箱:sales@amyjet.com

新闻中心
Logotype-SynthelisBiotech (1).png

<

艾美捷科技代理Synthelis Biotech品牌全系列产品


Synthelis Biotech是一家法国公司,专注于蛋白质的生产、纯化与表征,公司致力于助力疫苗、生物制剂、酶、工程蛋白、诊断工具以及高通量分子或配体筛选技术的开发。Synthelis Biotech提供经过验证的蛋白质,其活性和纯度均根据特定应用(候选药物筛选、抗体与疫苗开发、结构生物学、体外诊断、蛋白质载体化)量身定制。Synthelis Biotech专利的无细胞技术使客户能够从不同蛋白家族(GPCRs、离子通道、转运蛋白等)和不同形式(蛋白脂质体、纳米盘、去垢剂溶解形式或可溶形式)中选择合适的蛋白质。凭借其专利技术,Synthelis 能够在数小时内合成各类蛋白质:包括膜蛋白、毒性蛋白、修饰蛋白等,应用于药物筛选、疫苗与抗体开发、结构生物学以及体外诊断等领域。同时可按需进行修饰(荧光或同位素标记、非天然氨基酸掺入、截短或突变形式等)。


SynthelisBiotech页面.png


▍Synthelis Biotech产品列表


分类品名ProteinOriginFormatReferenceQuantity分子量
Viral ProteinsE1Envelop protein 1Hepatitis C virusProteoliposomePL01110µg, 20µg, 50µg, 100µg, 200µg, 500µg21 kDa
Viral ProteinsE2Envelop protein 1Hepatitis C virusProteoliposomePL01010µg, 20µg, 50µg, 100µg, 200µg, 500µg21 kDa
Viral ProteinsN-proteinNucleocapsid Protein (COVID-19)SARS-Cov 2 virusSolubleS-14410µg, 20µg, 50µg, 100µg, 200µg, 500µg47,7 kDa
Viral ProteinsF5LVaccinia virus major membrane proteinVaccinia virusProteoliposomePL00710µg, 20µg, 50µg, 100µg, 200µg, 500µg39.0 kDa
Viral ProteinsHCV p7Hepatitis C virus P7HCV virusProteoliposomePL04210µg, 20µg, 50µg, 100µg, 200µg, 500µg7 kDa
GPCRsAPJ/ARApelin ReceptorHumanProteoliposomePL06110 µg, 50 µg ,100 µg44.7 kDa
GPCRsB2RBradykinin receptor 2HumanProteoliposomePL08010 µg, 50 µg ,100 µg47.0 kDa
GPCRsBRBacteriorhodopsinBacteriaProteoliposomePL02710 µg, 50 µg ,100 µg29.4 kDa
GPCRsCCR1C-C chemokine receptor type 1HumanProteoliposomePL02110 µg, 50 µg ,100 µg43.7 kDa
GPCRsCCR2aC-C chemokine receptor type 2, isoform aHumanProteoliposomePL02210 µg, 50 µg, 100 µg44.5 kDa
GPCRsCCR2bC-C chemokine receptor type 2, isoform bHumanProteoliposomePL02310µg, 20µg,100 µg, 200 µg42 kDa
GPCRsCCR5C-C chemokine receptor type 5HumanProteoliposomePL02410µg, 20µg ,100 µg , 200 µg, 500 µg,bulk40 kDa
GPCRsCXCR4C-X-C chemokine receptor type 4HumanProteoliposomePL01610 µg, 50 µg, 100 µg43 kDa
GPCRsCXCR4-DetergentC-X-C chemokine receptor type 4HumanDetergentD01625µg ,100 µg ,500 µg,bulk40 kDa
GPCRsGLP1RGlucagon-like peptide 1 receptorHumanProteoliposomePL06710 µg, 50 µg, 100 µg55.5 kDa
GPCRsGPR50G-protein coupled receptor 50HumanProteoliposomePL09510 µg, 50 µg, 100 µg67.4 kDa
GPCRsGPR54G-protein coupled receptor 54HumanProteoliposomePL09710 µg, 50 µg ,100 µg45.2 kDa
GPCRsHMOPMu-type opioid receptorHumanProteoliposomePL025--
GPCRsMT1Melatonin receptorHumanProteoliposomePL02810µg, 20µg ,100 µg , 200 µg, 500 µg,bulk40 kDa
GPCRsRXFP1Relaxin receptor 1HumanProteoliposomePL06810 µg, 50 µg ,100 µg89.1 kDa
Ion Channelskir1.1bATP-sensitive inward rectifier potassium channel 1 isoform bMouseProteoliposomePL03110µg, 20µg,100 µg, 200 µg, 500 µg, bulk42.7 kDa
Ion Channelskv1.2Potassium voltage-gated channel subfamily A, member 2RatProteoliposomePL03710µg, 20µg ,100 µg , 200 µg, 500 µg,bulk57 kDa
Ion Channelskv1.3Potassium voltage-gated channel subfamily A, member 3MouseProteoliposomePL03610µg, 20µg ,100 µg , 200 µg, 500 µg,bulk58 kDa
Ion ChannelsVDAC1Voltage-Dependent Anion Channel 1HumanProteoliposomePL02910 µg, 50 µg ,100 µg30.7kDa
Ion ChannelsVDAC1 – DetergentVoltage-Dependent Anion Channel 1HumanDetergentD02910 µg, 50 µg, 100 µg30.7kDa
LigandsSDF1aStromal cell-derived factor 1HumanSolubleS06910 µg, 50 µg ,100 µg10.7 kDa
PorinsOEP24Outer envelope pore protein 24, chloroplasticPlantProteoliposomePL04010 µg, 50 µg ,100 µg24 kDa
PorinsOprFOuter membrane porin FBacteriaProteoliposomePL04510 µg, 50 µg, 100 µg40 kDa
Enzymesgp91phox (Nox2 subunit)gp91phoxHumanProteoliposomePL00810µg, 20µg ,100 µg , 200 µg, 500 µg,bulk55 kDa
EnzymesKMOKynurenine 3-monooxygenaseHumanProteoliposomePL00510µg, 20µg ,100 µg , 200 µg, 500 µg,bulk55,8 kDa
EnzymesNox2, p22 PhoxCytochrome b-245 light chainHumanProteoliposomePL03910 µg, 50 µg ,100 µg23,5 kDa
EnzymesNox4Nox4HumanProteoliposomePL05910µg, 20µg ,100 µg , 200 µg, 500 µg,bulk67 kDa
EnzymesPORCNProtein-Cysteine N-palmitoyltransferase porcupineHumanProteoliposomePL00610 µg, 50 µg, 100 µg55.5 kDa
EnzymesTFTissue factorHumanProteoliposomePL05310µg, 20µg ,50µg, 100 µg , 200µg, 500 µg,bulk33 kDa
EnzymesT7 RNA PolT7 RNA PolymeraseBacteriophage T7SolubleS19210 µg, 50 µg, 100µg100.1 kDa
EnzymesDsbCDisulfide bond isomeraseE.coliSolubleS197customized quantity on request.25.4 kDa
ReceptorsCLDN 18.2Claudin 18.2 ProteinHumanProteoliposomePL11910 µg, 50 µg, 100 µg30 kDa
Transcriptional regulatorsAROSActive regulator of SIRT1HumanProteoliposomeS05210µg, 20µg ,100 µg , 200 µg, 500 µg,bulk15,4 kDa
TransportersBakBcl-2 homologous antagonist killerHumanProteoliposomePL03825µg ,100 µg ,500 µg,bulk17 kDa
TransportersEspHCytoskeleton-modulating effector of enterohaemorrhagic and enteropathogenic Escherichia coliBacteriaProteoliposomePL05110 µg, 50 µg, 100 µg21.9 kDa
TransportersHCV p7Hepatitis C virus P7VirusProteoliposomePL04225µg ,100 µg ,500 µg,bulk7 kDa
TransportersNhaANa(+)/H(+) antiporter NhaAE. coliProteoliposomePL03210 µg, 50 µg, 100 µg43.9 kDa
TransportersUCP1Mitochondrial brown fat uncoupling protein 1MitochondriaProteoliposomePL04710 µg, 50 µg, 100 µg35.1 kDa
" data-original="http://apexbio.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Synthelis Biotech品牌全系列产品">
艾美捷科技代理Synthelis Biotech品牌全系列产品
...
阅读详情
logo.jpg

<

艾美捷科技代理Helvetica Health Care品牌全系列产品


Helvetica Health Care是一家位于瑞士日内瓦的医疗保健公司,致力于通过创新的产品和技术来管理健康和提高生活质量。作为瑞士生物技术协会的成员,Helvetica Health Care通过了ISO 13485认证,在质量和创新方面坚持最高标准。涵盖各种质量控制和验证面板,适用于不同的分子测试平台和检测。这些产品有多种规格,可用于单一或多种分析物的检测,帮助实验室监控测试性能,确保测试的准确性和可靠性。其质量控制和验证组合可根据产品配置、填充量和分析物浓度进行定制,满足不同平台的需求。


▎Helvetica Health Care产品线

Helvetica Health Care公司的产品涵盖:抗体、生命科学产品、血液分离产品、临床/诊断样本、质控品与标准品、分子生物学产品、细胞因子与生长因子、ELISA试剂盒/Western印迹相关产品、微生物、氧化应激产品、诊断产品以及人血浆制品。


HelveticaHealthCare页面.png


▎Helvetica Health Care部分产品列表


货号产品描述
NATFRC-6CNATtrol Flu/RSV/SARS-CoV-2 Positive Control (6 x 0.5mL)
NATCV9-6CNATtrol Flu/RSV/SARS-CoV-2 Negative Control (6 x 0.5mL)
NATRPC2.1-BIONATtrol Respiratory Panel 2.1 (RP2.1) Controls (12 x 0.3mL)
NATRVP2.1-BIONATtrol Respiratory Verification Panel 2.1 (24 x 0.6mL) (EA)
NATRVP2.1-BIO PlusNATtrol Respiratory Verification Panel 2 Plus (+NATCOV(MR)-BIO) (24x 0.6 ml + 1x 0.6 ml)
NATRVP2-QIANATtrol Respiratory Verification Panel 2 (21 x 0.25mL) (EA)
NATSARS(COV2)-VPNATtrol SARS-CoV-2 Variant Panel (4 x 0.5mL)
NATSARS(COV2)-ERCSARS-Related Coronavirus 2 (SARS-CoV-2) External Run Control (6 x 0.5 mL)
NATSARS(COV2)-ERC1NATtrol SARS-Related Coronavirus 2 (SARS-COV-2) Positive Control (6x 1.0 ml)
NATSARS(COV2)-NEGSARS-Related Coronavirus 2 (SARS-CoV-2) Negative Control (6 x 0.5 mL)
NATSARS(COV2)-NEG1NATtrol SARS-Related Coronavirus 2 (SARS-COV-2) Negative Control (6x 1.0 ml)
NATSARS(COV2)-STSARS-Related Coronavirus 2 (SARS-CoV-2) Stock
NATSARS(COV2-SA)-STNATtrol SARS-Related Coronavirus 2 (SARS-CoV-2) Variant B.1.351 Stock (1mL)
NATSARS(COV2-UK)-STNATtrol SARS-Related Coronavirus 2 (SARS-CoV-2) Variant B.1.1.7 Stock (1mL)
0810229-0.5mgCoronavirus 229E Lysate (0.5 mg)
0810587SARS-CoV-2 (Isolate: USA-WA1/2020) Lysate (1 mg)
0810587-0.5mgSARS-CoV-2 (Isolate: USA-WA1/2020) Lysate (0.5 mg)
0810587CFHI-0.5mLSARS-CoV-2 (Isolate: USA-WA1/2020) Culture Fluid (Heat Inactivated) (0.5 mL)
0810587CFHISARS-CoV-2 (Isolate: USA-WA1/2020) Culture Fluid (Heat Inactivated) (1.0 mL)
0810587UVSARS-CoV-2 (Isolate: USA-WA1/2020) Culture Fluid (UV Inactivated) (1 mL)
0810589CFHISARS-CoV-2 (Isolate: Italy-INMI1) Culture Fluid (Heat Inactivated) (1 mL)
0810589UVSARS-CoV-2 (Isolate: Italy-INMI1) Culture Fluid (UV Inactivated) (1 mL)
0810590CFHISARS-CoV-2 (Isolate: Hong Kong/VM20001061/2020) Culture Fluid (Heat Inactivated) (1 mL)
0810590UVSARS-CoV-2 (Isolate: Hong Kong/VM20001061/2020) Culture Fluid (UV Inactivated) (1 mL)
0810617UVSARS-CoV-2 Lineage P1_2021; Gamma Variant (NY-Wadsworth-21033899-01/2021) Culture Fluid (UV))
0810618UVSARS-CoV-2 Lineage P2_2021; Zeta Variant (NY-Wadsworth-21006055-01/2021) Culture Fluid (UV)
0810619UVSARS-CoV-2 Iso1 Lin B.1.526_2021 Iota (NY-Wadsworth-21025952-01/2021) CF (UV Inactivated)
0810620UVSARS-CoV-2 Iso2 Lin B.1.526_2021 Iota (NY-Wadsworth-21025952-01/2021) CF (UV Inactivated)
0810621UVSARS-CoV-2 Lineage B.1_2020 (NY-Wadsworth-103677-01/2020) CF (UV Inactivated)
0810622UVSARS-CoV-2 Lineage B.1.595_2020 (NY-Wadsworth-33126-01/2020) CF (UV Inactivated)
0810612CFHISARS-CoV-2 Variant B.1.1.7 (Isolate:USA/CA_CDC_5574/2020) Culture Fluid (Heat Inactivated) (1 mL)
0810612UVSARS-CoV-2 Lineage B.1.1.7; Alpha Variant (USA/CA_CDC_5574/2020) CF (UV Inactivated) (1 mL)
0810613CFHISARS-CoV-2 Variant B.1.351(Isolate:South_Africa/KRISP-K005325/2020) CF (Heat Inactivated) (1 mL)
0810613UVSARS-CoV-2 Lineage B.1.351; Beta (South_Africa/KRISP-K005325/2020) CF (UV Inactivated) (1 mL)
0810614CFHISARS-CoV-2 Variant B.1.1.7 (Isolate:England/204820464/2020) Culture Fluid (Heat Inactivated) (1 mL)
0810614UVSARS-CoV-2 Lineage B.1.1.7 Alpha Variant (England/204820464/2020) CF (UV Inactivated) (1 mL)
0810616CFHISARS-CoV-2 Lineage P1; Gamma Variant (Japan/TY7-503/2021) CF (Heat Inactivated) (1 mL)
0810616UVSARS-CoV-2 Lineage P1; Gamma Variant (Isolate: Japan/TY7-503/2021) CF (UV Inactivated) (1 mL)
0810617CFHISARS-CoV-2 Lineage P1_2021; Gamma Variant (NY-Wadsworth-21033899-01/2021) – CFHI (1.0 ml)
0810618CFHISARS-CoV-2 Lineage P2_2021; Zeta Variant (NY-Wadsworth-21006055-01/2021) – CFHI (1.0 ml)
0810619CFHISARS-CoV-2 Lso1 Lin B.1.526_2021 Lota (NYWadsworth-21025952-01/2021) – CFHI (1.0 ml)
0810620CFHISARS-CoV-2 Lso2 Lin B.1.526_2021 Lota (NYWadsworth-21025952-01/2021) – CFHI (1.0 ml)
0810621CFHISARS-CoV-2 Lineage B.1_2020 (NY-Wadsworth-103677-01/2020) – CFHI (1.0 ml)
0810622CFHISARS-CoV-2 Lineage E3.1.595J2020 (NYWadsworth-33126-01/2020) – CFHI (1.0 ml)
0810623UVSARS-CoV-2 Lineage B.1.617.1 Kappa Variant (USA/CA-Stanford-15_S02/2021) CF (UV Inactivated)
0810623CFHISARS-CoV-2 Lineage B.1.617.1 Kappa Variant (USA/CA-Stanford-15_S02/2021) CF (Heat Inactivated)
0810624UVSARS-CoV-2 Lineage B.1.617.2; Delta Variant (USA/PHC658/2021) CF (UV Inactivated)
0810624CFHISARS-CoV-2 Lineage B.1.617.2; Delta Variant (USA/PHC658/2021) CF (Heat Inactivated)
0820010CFHIVeroE6 Culture Fluid (Heat Inactivated) (1 mL)
0801043Goat Anti-SARS-CoV-2 Polyclonal Serum (0.5 ml)
0831042SARS-CoV-2 (recombinant) Stock (1 x 1.0 mL)
0831043SARS-CoV-2 (E/ORF1ab recombinant) Stock (1 x1.0mL)
NATSARS-STCoronavirus SARS Stock (Qualitative) (1 mL)
NATCOV(229E)-STCoronavirus 229E Stock (Qualitative) (1 mL)
0810229CFHICoronavirus (Strain: 229E) Culture Fluid (Heat Inactivated) (1 mL)
0810229Coronavirus Strain: 229E Lysate
0810229UVCoronavirus (Strain: 229E) Culture Fluid (UV Inactivated) (1 mL)
NATCOV(NL63)-STCoronavirus NL63 Stock (Qualitative) (1 mL)
0810228CFHICoronavirus (Strain: NL63) Culture Fluid (Heat Inactivated) (1 mL)
0810228Coronavirus Strain: NL63 Lysate
0810228UVCoronavirus (Strain: NL63) Culture Fluid (UV Inactivated) (1 mL)
NATCOV(OC43)-STCoronavirus OC43 Stock (Qualitative) (1 mL)
0810024CFHICoronavirus (Strain: OC43) Culture Fluid (Heat Inactivated) (1 mL)
0810024Coronavirus Strain: OC43 Lysate
NATMERS-STMERS-CoV Stock (Qualitative) (1 mL)
NATMR-BIONATtrol MERS Recombinant Pack (2x 0.2 ml +0.5 ml)
NATCOV(MR)-BIONATtrol MERS-S. Cerevisiae (0.6 ml)
0810575MERS-COV (Strain: Florida/USA-2_Saudi Arabia_2014) Lysate(1mg)
0810575-0.5mgMERS-COV (Strain: Florida/USA-2_Saudi Arabia_2014) Lysate(0.5mg)
CV033122COVID-19 Cross Over Panel (40x 1.0 ml)




" data-original="http://apexbio.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Helvetica Health Care品牌全系列产品">
艾美捷科技代理Helvetica Health Care品牌全系列产品
...
阅读详情
Pel-Freez LOGO 2.5比1.jpgexocell.jpg

艾美捷科技代理Pel-Freez 品牌。

在20世纪50年代,为了响应生物医学研究人员对材料的大量需求,Pel-Freez公司扩展到动物生物制品领域,并从那时起一直为生物医学界服务。在过去的几十年里,Pel-Freez进一步扩大了其产品范围。Pel-Freez提供包括各种动物组织、提取物和血液制品以及关键的人类生物制品。这些产品广泛应用于体外诊断试剂盒开发、药物发现、疫苗评估、HLA分型等领域。


Pel-Freez产品包括:

(1)冻干组织粉:提供多种动物组织的冻干粉,便于储存和使用,适用于各种生物化学和分子生物学实验。

(2)血清产品:包括正常兔血清和其他物种的血清产品,如人血清、人血浆等,用于细胞培养和生物医学研究。

(3)血浆和血液补体:提供人血浆和血液补体产品,用于免疫学研究和补体系统的功能分析。

(4)组织和抗体:提供多种组织的提取物和特异性抗体,支持基础研究和诊断开发。


Pel-Freez拥有专有的分离技术,能够去除超过96%的背景LGG和LGM抗体,同时保持补充功能。此外,其所有产品都经过高度标准化的生产过程,确保质量稳定可靠。Pel-Freez在疫苗开发用途兔补体方面是行业领导者,其热销产品涵盖人补体、成年(幼)兔补体、豚鼠补体等各类。Pel-Freez的客户群体包括全球的科研机构、制药公司、生物技术公司和临床诊断实验室,以及疫苗研究与开发领域的专家。Pel-Freez通过ISO 9001认证,确保其产品的质量和一致性。此外,其工厂和农场也遵循严格的伦理和人道动物实践标准。


<<<<< " data-original="http://apexbio.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Pel-Freez品牌">
艾美捷科技代理Pel-Freez品牌
...
阅读详情
LKT Labs.png

LKT Labs是一家专注于特殊化学品研究和开发的公司。主要提供:药物发现试剂盒、天然产物、广泛的生命科学研究试剂、定制合成。美国LKT Labs 是1988年在美国成立的,为全球提供先端的药物研发试剂、试剂盒、委托合成,并为药物生产企业提供原料。

 

LKT Laboratories is a biochemical supply company focused on the synthesis, purification, and isolation of small molecules for research applications. Its range of products exhibit known biological activities that have found uses in a wide array of research fields, especially cancer and neuroscience. These products include protein kinase inhibitors, ion channel modulators, and activators.

 

Originally established in 1989 as a research company doing government grant work with exactly these types of molecules, LKT Labs has a unique understanding of the needs of its customers. Its goal is to provide laboratories around the world with a reliable and diverse source of high purity biochemicals with a particular focus on product quality, availability, and customer support.

 

LKT Labs产品范围:

Cancer Biology

Cardiovascular

Endocrine Signaling and Immunology

Metabolic and GI Pathology

Microbiology

Natural Products

Neuroscience

Peptides

<

更多详情请联系 

艾美捷科技有限公司

全国服务热线:400-6800-868

邮箱:sales@amyjet.com

网站:www.amyjet.com

" data-original="http://apexbio.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="LKT Labs">
LKT Labs
...
阅读详情

Copyright © 2026 Powered by APExBIO中国区代理商/公司/官网   鄂ICP备10204150号-10 sitemap